Oncology

The Department of Oncology of Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine is a “Key Discipline in Oncology” of the Shanghai Municipal Education Commission and a key clinical oncology discipline of Shanghai designated as a “top priority among priorities.” In the 2022 annual ranking of the competitiveness of disciplines in municipal hospitals released by the Shanghai Health and Health Development Research Center, Renji Oncology ranked 2nd in 2022, second only to Cancer Hospital, and ranked 1st among general hospitals. In the national ranking of research competitiveness in oncology, it ranked 9th. The Department of Oncology has 42 approved beds (East Campus 38 + South Campus 4), 23 doctors, and 23 nurses. The doctors are distributed across Renji East Campus, South Campus, and the Punan, Baoshan, Ningbo, and Nantong branch hospitals. Among the doctors, 13 are Party members (59%), 12 hold senior professional titles (55%), and 19 hold doctoral degrees (86%). Under the leadership of the current head of the department, Director Xiao Xiuying, the Department of Oncology provides full-lifecycle management for patients with various solid tumors and carries out individualized, standardized, and precision comprehensive treatment. It also performs minimally invasive tumor biopsy, hyperthermia, irreversible electroporation ablation therapy (nanoknife ablation), and placement and maintenance of implantable venous infusion ports (PORT). It has also become a national clinical trial base for oncology drugs, undertaking clinical research on multiple new oncology drugs each year. A total of 15 clinical research projects have been conducted; 13 have been completed, 8 projects are pending initiation, including 7 led by the department, 2 international multicenter projects, and 12 domestic multicenter projects. In 2023, the department received 5 National Natural Science Foundation grants, won the Shanghai Medical Science and Technology First Prize, and received 1 project from the Shanghai Municipal Science and Technology Commission. It published 16 SCI papers as first or corresponding author. The department is the lead institution of the expert group for oncology specialist physician training of Shanghai Jiao Tong University School of Medicine and a Shanghai standardized training base for medical oncology and oncology specialists. It undertakes oncology teaching for the Shanghai—Ottawa Joint Medical College and the 8-year program of Shanghai Jiao Tong University School of Medicine. In 2023, 2 people were recognized as advanced individuals in hospital teaching work; 6 people received first, second, and third prizes in the case competition of Shanghai Jiao Tong University School of Medicine and recognition for the top ten exemplary teaching plans. The department is currently the institution of the chairperson of the Pancreatic Cancer Expert Committee of the Chinese Society of Clinical Oncology, the lead institution of the Pancreatic Tumor Group of the Oncology Branch of the Chinese Medical Association, and a member institution of the Professional Committee of Integrated Onco-Nephrology of the Chinese Anti-Cancer Association; it is also the institution of the deputy chairperson of the Oncology Specialty Branch of the Shanghai Medical Association and a member institution of the Special Committee on Difficult and Complex Tumors of the Shanghai Anti-Cancer Association. The Department of Oncology will focus on the professionalization and refinement of disciplinary development, build a clinical medical and academic team with a complete range of specialties, distinctive characteristics, a complete personnel echelon, effective management, and comprehensive development in medical care, education, and research, further enhance its domestic reach and international recognition, and lay the foundation for the discipline to join the ranks of internationally first-class disciplines.